Trial Profile
High volume haemodiafiltration in treatment of severe sepsis -- impact on pharmacokinetics of doripenem and piperacillin tazobactam and inflammatory response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Doripenem (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Sepsis; Septic shock
- Focus Pharmacokinetics
- 01 Jun 2011 New trial record